Bullock Wealth Management’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Bullock Wealth Management's DFTX Position: Q3 2026 in Review
Bullock Wealth Management held its Definium Therapeutics (DFTX) position steady in Q3 2026 at 907 shares worth $34.1K. The position accounts for 0.01% of the portfolio, ranked #318.
Bullock Wealth Management first reported a position in DFTX in Q3 2021 and has held it in 11 quarters since. The position peaked at $39.4K in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Bullock Wealth Management held 907 shares of Definium Therapeutics worth $34.1K as of Q3 2026.
- Bullock Wealth Management left its Definium Therapeutics share count unchanged in Q3 2026.
- Definium Therapeutics made up 0.01% of Bullock Wealth Management's portfolio in Q3 2026, its #318 holding.
- Bullock Wealth Management first reported a position in Definium Therapeutics in Q3 2021 and has held it in 11 quarters since.
- Bullock Wealth Management's Definium Therapeutics position peaked at $39.4K in Q2 2026.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Bullock Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.